SCNIScinai Immunotherapeutics Ltd.
Earnings
When Scinai Immunotherapeutics Ltd. reports, what it reported each quarter, and how the stock took the results.
7 quarters. Sep 30, 2019 to Jun 30, 2023. mixed units.
Latest results
- Q1 2023May 15, 2023, after the close
- Revenue
- —
- —
- Net income
- -$3.52M
- N/M
- EPS
- -$0.00
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2023 | ||||||||||
| Q2 2023 | Jun 30, 2023 | — | — | — | — | — | — | -$0.00 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | — | — | -$0.00 | — | |
| FY 2022 | ||||||||||
| Q2 2022 | Jun 30, 2022 | — | — | — | — | — | — | -$0.00 | — | |
| Q1 2022 | Mar 31, 2022 | — | — | — | — | — | — | -$0.00 | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | — | — | — | — | — | — | — | — | |
| FY 2020 | ||||||||||
| Q3 2020 | Sep 30, 2020 | — | — | — | — | — | — | $0.10 | — | |
| FY 2019 | ||||||||||
| Q3 2019 | Sep 30, 2019 | — | — | — | — | — | — | -$0.05 | — | |
Earlier years, FY 2019 to FY 2020The latest three years
Source filings
Provenance
ProvenanceData status and checks
Scinai Immunotherapeutics Ltd. · CIK 1611747 · Engraved from SEC EDGAR